The Year in Review session during ACR Convergence 2020 will address advances in clinical and basic science related to rheumatology, including drug safety, precision medicine, the COVID-19 pandemic and more.
Search results for: cancer
Nancy Bates Allen, MD, in the Spotlight
Nancy Bates Allen, MD, now professor emeritus, Duke University Medical School, Division of Rheumatology and Immunology, Durham, N.C., created a legacy of clinical care, clinical research, advocacy for women and collegial respect during her 42-year career at Duke. David S. Caldwell, MD, FACP, FACR, associate professor of medicine, Duke University School of Medicine, says, “[I’m]…
The Reliability & Utility of Serological Antibody Tests in COVID-19
Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…
Dendritic Cells as Therapeutics: The New Frontier
Cancer treatments, organ transplants and rheumatologic diseases—dendritic cells are being used throughout medicine to create innovative treatments, according to presenters of a virtual session during the European e-Congress of Rheumatology.
Self-Administered Acupressure Promising for Chronic Back Pain Relief
Researchers examined the benefits of two acupressure approaches for treating low back pain, finding that patients who self-administered stimulating acupressure experienced a significant decrease in fatigue associated with their chronic pain…
U.S. Hip Fracture Incidence Declines with Reductions in Smoking & Drinking
(Reuters Health)—Age-adjusted hip fracture incidence has declined in the U.S. over the past four decades, aided by a decline in smoking and alcohol consumption, a new study suggests. Researchers examined data on 4,918 men and 5,634 women who participated in the prospective Framingham Heart Study from 1970 to 2010. Overall, the age-adjusted incidence of hip…
Insights into Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
Recent research found inflammatory arthritis caused by immune checkpoint inhibitors (ICIs) may become a long-term disease, requiring rheumatology care and immunomodulatory treatment. Some patients experience active inflammatory arthritis years after ICI cessation…
In Memoriam … J. Timothy Harrington, MD, MACR: July 6, 1940–June 23, 2020
June saw the passing of a beloved colleague, mentor and friend to many in the rheumatology community when J. Timothy Harrington, MD, died of pancreatic cancer in his hometown of Madison, Wis. Dr. Harrington trained at Massachusetts General Hospital, the National Institutes of Health National Cancer Institute and UT Southwestern Medical Center, and served on…
Spring 2020’s Awards, Appointments & Announcements in Rheumatology
Keith Sullivan, MD, Receives Lifetime Achievement Award Mentorship, collaboration and a quest for cure shine through as major themes in the distinguished career of Keith M. Sullivan, MD, the James B. Wyngaarden Professor of Medicine, Duke University Medical Center, Durham, N.C. On Friday, Feb. 21, those themes dominated his acceptance speech when he received a…
A Peaceful Medical Mission in Guatemala, Days before COVID-19
My first-ever medical mission trip, after 37 years of medical practice, was to Teleman, Alta Verapaz, Guatemala. Prior to the trip, my excitement as an adult-trained rheumatologist was balanced against my apprehension about witnessing new diseases, caring for children and practicing in an austere environment with limited medical resources. As directed by the travel clinic,…
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 86
- Next Page »